Abbott introduces TriClip™ in India, a first-of-its kind device to repair a leaky tricuspid valve
Abbott introduces TriClip™ in India, a first-of-its kind device to repair a leaky tricuspid valve TriClip offers a safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery Clinical evidence shows TriClip can reduce valve leakage and deliver meaningful, lasting improvements in patients’ everyday lives NEW DELHI, May 11, 2026 — Abbott, a global healthcare leader, today announced the launch of the TriClip™ transcatheter edge-to-edge repair (TEER) system in India. This device is specifically designed for the treatment of tricuspid regurgitation (TR) or a leaky tricuspid valve. Delivered through a vein in the leg, TriClip's TEER technology works by clipping together a portion of the leaflets – or flaps of tissue – to repair the tricuspid valve and help blood flow in the right direction without the need for open-heart surgery. It leverages the technology and robust body of evidence from the MitraClip device, t...